Business

Zydus Cadila announces phase III trials of Desidustat

Zydus Cadila announces phase III trials of Desidustat "This phase III study will be a multicenter (50-60 sites), randomised, active-controlled clinical trial to evaluate the efficacy and safety of Desidustat versus Darbepoetin for the treatment of anaemia in patients with chronic kidney disease (CKD) who are not on dialysis," the company said in a regulatory filing.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts